Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
1.32M
-
Shares change
-
+271K
-
Total reported value, excl. options
-
$7.15M
-
Value change
-
+$1.39M
-
Number of buys
-
19
-
Number of sells
-
-15
-
Price
-
$5.41
Significant Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q4 2024
38 filings reported holding NVCT - Nuvectis Pharma, Inc. - COM as of Q4 2024.
Nuvectis Pharma, Inc. - COM (NVCT) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.32M shares
.
Largest 10 shareholders include BALDWIN WEALTH PARTNERS LLC/MA (356K shares), VANGUARD GROUP INC (325K shares), MARSHALL WACE, LLP (125K shares), GEODE CAPITAL MANAGEMENT, LLC (79.2K shares), BlackRock, Inc. (62.3K shares), FORBES J M & CO LLP (59K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (45.6K shares), GSA CAPITAL PARTNERS LLP (34.8K shares), Qube Research & Technologies Ltd (30.6K shares), and MILLENNIUM MANAGEMENT LLC (29.7K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.